Following Cas9 cleavage, DNA repair without a donor template is generally considered stochastic, heterogeneous and impractical beyond gene disruption. Here, we show that template-free Cas9 editing is predictable and capable of precise repair to a predicted genotype, enabling correction of disease-associated mutations in humans. We constructed a library of 2,000 Cas9 guide RNAs paired with DNA target sites and trained inDelphi, a machine learning model that predicts genotypes and frequencies of 1-to 60-base-pair deletions and 1-base-pair insertions with high accuracy (r = 0.87) in five human and mouse cell lines. inDelphi predicts that 5-11% of Cas9 guide RNAs targeting the human genome are 'precise-50', yielding a single genotype comprising greater than or equal to 50% of all major editing products. We experimentally confirmed precise-50 insertions and deletions in 195 human disease-relevant alleles, including correction in primary patient-derived fibroblasts of pathogenic alleles to wild-type genotype for Hermansky-Pudlak syndrome and Menkes disease. This study establishes an approach for precise, template-free genome editing.
. The DNA-targeting capabilities of Cas9 have been improved by the development of guide RNA (gRNA) design principles 4 , modelling of factors leading to off-target DNA cleavage, enhancement of Cas9 sequence fidelity by modifications to the nuclease and gRNA, and the evolution or engineering of Cas9 variants with alternative PAM sequences 5 . Similarly, control over the product distribution of genome editing has been advanced by the development of base editing to achieve precise and efficient single-nucleotide mutations 6, 7 , and the improvement of template-directed homology-directed repair (HDR) of double-stranded breaks 8 . Despite these developments, base editing does not mediate insertions or deletions, and HDR is limited by low efficiency, particularly in non-dividing cells, and by undesired by-products. As many human genetic variants associated with disease arise from insertions and deletions 9, 10 , methods to efficiently introduce insertions and deletions to alleviate pathogenic mutations in a predictable manner with a major single-genotype outcome would advance the field of genome editing.
Non-homologous end joining (NHEJ) and microhomologymediated end joining (MMEJ) processes are major pathways involved in the repair of Cas9-mediated double-stranded breaks that can result in highly heterogeneous repair outcomes comprising hundreds of repair genotypes. Although end-joining repair of Cas9-mediated double-stranded DNA breaks has been harnessed to facilitate knock-in of DNA templates 11, 12 or deletion of intervening sequence between two cleavage sites 5 , NHEJ and MMEJ are not generally considered useful for precision genome editing applications. Previous work has found that the heterogeneous distribution of Cas9-mediated editing products at a given target site is reproducible and dependent on local sequence context 13, 14 , but no general methods have been described to predict genotypic products following Cas9-induced double-stranded DNA breaks.
In this study, we developed a high-throughput Streptococcus pyogenes Cas9 (SpCas9)-mediated repair outcome assay to characterize end-joining repair products at Cas9-induced double-stranded breaks using 1,872 target sites based on sequence characteristics of the human genome. We used the resulting rich set of repair product data to train inDelphi, a machine learning algorithm that accurately predicts the frequencies of the substantial majority of template-free Cas9-induced insertion and deletion events at single-base resolution (https:// indelphi.giffordlab.mit.edu/). We find that, in contrast to the notion that end-joining repair is heterogeneous, inDelphi identifies that 5-11% of SpCas9 gRNAs in the human genome induce a single predictable repair genotype in ≥50% of editing products. Building on this idea of precision gRNAs, we used inDelphi to design 14 gRNAs for highprecision template-free editing yielding predictable 1-bp insertion genotypes in endogenous human disease-relevant loci and experimentally confirmed highly precise editing (median 61% among edited products) in two human cell lines. We used inDelphi to reveal human pathogenic alleles that are candidates for efficient and precise template-free gainof-function genotypic correction and achieved template-free correction of 183 pathogenic human microduplication alleles to the wild-type genotype in ≥50% of all editing products. Finally, we integrate these developments to achieve high-precision correction of five pathogenic low-density lipoprotein receptor (LDLR) microduplication alleles in human and mouse cells, as well as correction of endogenous pathogenic microduplication alleles for Hermansky-Pudlak syndrome (HPS1) and Menkes disease (ATP7A) to the wild-type sequence in primary patient-derived fibroblasts.
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Template-free Cas9 editing is predictable
To capture Cas9-mediated end-joining repair products across a wide variety of target sites, we designed a genome-integrated gRNA and target library screen in which many unique gRNAs are paired with 55-bp target sites containing a single canonical 'NGG' SpCas9 protospaceradjacent motif (PAM) that directs cleavage to the centre of each target site (Fig. 1a) . Previously reported repair products at 90 loci in three human cell lines 14 (HCT116, K562, and HEK293; we refer to the collective data set as VO) showed that 94% of endogenous cut-site proximal Cas9-mediated deletions are ≤30 bp (Extended Data Fig. 1 ), suggesting that our assay can assess the vast majority of cut-site-proximal editing products. To explore repair products among sequences representative of the human genome, we designed 1,872 target sites spanning the distributions of GC content, number of nucleotides participating in microhomology, predicted Cas9 on-target cutting efficiency 4 , and estimated precision of deletions 14 (Supplementary Methods, Extended Data Fig. 1 ), as well as 90 VO target sites to create a library (denoted hereafter as 'lib-A') in which each target site is accompanied by a corresponding gRNA on the same DNA molecule. Through a multi-step process (Extended Data Fig. 1 ), we constructed and cloned lib-A into a plasmid backbone allowing Tol2 transposon-based integration into the genome 15 , gRNA expression and hygromycin selection for cells with library members.
We stably integrated lib-A into the genomes of mouse embryonic stem cells (mESCs) and human U2OS cells, then targeted these cells with a Tol2 transposon-based SpCas9 expression plasmid containing a blasticidin expression cassette and selected for cells with stable Cas9 expression while maintaining more than 2,000-fold coverage of the library. After one week, we collected genomic DNA from these cells (three independent biological replicates in mESCs, two in U2OS cells) along with control cells not treated with Cas9 (one in each) and performed paired-end high-throughput DNA sequencing (HTS) to reveal the distribution of cut-site-proximal repair products at each target site (Extended Data Fig. 1 ). We tabulated the resulting 192,055,534 sequencing reads using a sequence alignment procedure (Supplementary Methods) that identified an average of 245 unique repair outcomes with high confidence (Supplementary Methods) per target site in mESCs (45 in U2OS cells) after adjusting with control data. Repair outcomes in experimental replicates within the same cell type were consistent (median r = 0.89 in mESCs, 0.77 in U2OS cells, Extended Data Fig. 1) .
In lib-A data from mESCs and U2OS cells as well as in endogenous data in HEK293, K562 and HCT116 cells, end-joining repair of Cas9-mediated double-stranded breaks primarily caused deletions (on average 63-87% of all edited products across cell types) and insertions (13-37% of all products) ( (Fig. 1b, c) : microhomology (MH) deletions, microhomology-less (MH-less) deletions, and single-base (1-bp) insertions; we define these three repair classes as constituting all major editing outcomes. The insertion and deletion (indel) frequencies at 86 target sites were consistent between endogenous data in HEK293, K562 and HCT116 cells and lib-A data in mESCs and U2OS cells (median r = 0.65 to 0.82 for pairs of cell types when adjusting for 1-bp insertion frequencies, median r = 0.52 to 0.76 without adjustment, Extended Data Fig. 1 ). Together, these data confirm that Cas9-mediated editing products from our library assay reflect previously reported endogenous editing in human cells.
Using lib-A, we designed a new machine learning model, inDelphi, to predict the frequency of all major editing outcomes at any given target site. This model consists of three interconnected modules aimed at predicting MH deletions, MH-less deletions and 1-bp insertions (Fig. 1e) .
inDelphi predicts MH deletions using a module that simulates the MMEJ repair mechanism, in which 5′-3′ end resection at a doublestranded break reveals two 3′ single-stranded DNA overhangs that can anneal through sequence microhomology. Extraneous single-stranded DNA overhangs are eliminated, and DNA synthesis and ligation generates a double-stranded DNA repair product 16 ( Fig. 1d ). Through this mechanism, each microhomology results in a distinct deletion genotype (Fig. 1d, Supplementary Discussion) . inDelphi assigns a score (phi) to a candidate microhomology based on a neuralnetwork-learned score using its length and GC content with a penalty based on the deletion length. Relative frequencies are obtained by normalizing the phi scores of microhomologies of interest to sum to one, thereby modelling MH deletions as a competitive process.
inDelphi models deletions inconsistent with MMEJ with a second neural network module that predicts the total frequency of groups of MH-less deletion outcomes using the minimum required resection length as the only input feature (Fig. 1e) . We hypothesize that MH-less deletions arise primarily from the classical and alternative NHEJ pathways 17 (Supplementary Discussion). The MH and MH-less neural networks were jointly trained using data from 1,095 lib-A target sites in mESCs with backpropagation in a multi-task manner to predict both deletion length frequencies Article reSeArcH and MH genotype frequencies (Fig. 1e, Supplementary Methods) . Computational experiments confirmed that the design of the neural network modules was important for overall performance (Supplementary Methods). From training data, inDelphi learned that strong microhomologies tend to be long and have high GC content and that the frequency of MH-less deletions decays rapidly with increasing length (Extended Data Fig. 2 ). For 1-to 30-bp deletions, at a typical target site in the human genome, inDelphi makes one prediction for each of 92 possible MH deletions, and 30 predictions for 274 possible MH-less deletion genotypes.
inDelphi contains a third module that uses k-nearest neighbours to predict 1-bp insertions (Fig. 1e ), which represent a major class of edited products (9-30% of all edited products, Fig. 1b , Extended Data Fig. 2 ). The frequency of 1-bp insertions and their resultant genotypes depend strongly on local sequence context. They are predominantly duplications of the −4 nucleotide (counting the NGG PAM as nucleotides 0-2, Fig. 1e ), with higher precision and frequency when the -4 nucleotide is an A or T (Fig. 2a, b) . A linear regression model trained to predict the frequency of 1-bp insertions among major editing outcomes from local sequence context performed well on held-out lib-A target sites (that is, those not included in the training of the model) in mESCs (n = 499, r = 0.63, Fig. 2c ) and U2OS cells (n = 492, r = 0.65, Extended Data Fig. 3 ). In both cell types, target sites with weak microhomology (low total phi score) or low deletion precision score (Supplementary Methods) were significantly more likely to yield insertions at the expense of deletions (P < 2.0 × 10
, Extended Data Fig. 3 ). Randomization of four nucleotides surrounding the Cas9 cleavage site in three constant background sequences with weak microhomology revealed substantial variation in 1-bp insertion frequency (from ≤5% to ≥80% of all edited products, Fig. 2d, Extended Data Fig. 3 ) and identified mini-motifs consistent with lib-A (Fig. 2e) , suggesting that local sequence context is a highly influential and causal factor for 1-bp insertion repair.
On the basis of these data, inDelphi models insertions and deletions as competitive processes in which microhomology strength and precision of deletions influence the relative frequency of 1-bp insertions, and local sequence context influences the relative frequency and genotypic outcomes of 1-bp insertions (Fig. 1e) . inDelphi makes predictions within each module in a cell-type-invariant manner, only using cell-type-specific data to predict the overall ratio of 1-bp insertions to deletions. Collectively across all three modules, inDelphi predicts the indel lengths of 80-95% of Cas9-mediated editing products and the genotypes of 65-80% of all products (Fig. 3a, Extended Data Fig. 4 ) from sequence context alone.
inDelphi achieves high accuracy in predicting genotype frequencies (median r = 0.94) and indel length frequency distributions (median r = 0.91) in 189 held-out lib-A target sites in mESCs (Extended Data  Fig. 4) , with similarly high accuracy in U2OS cells (median r = 0.88 and 0.91, Extended Data Fig. 4 ). On held-out endogenous data, inDelphi also performed strongly on the two tasks (median r = 0.87 and 0.84 across 87-90 target sites in K562, HCT116 and HEK293 cells, Fig. 3b, c) . Taken together, these results establish that in data from five human and mouse cell lines, the relative frequencies of most Cas9-nucleasemediated editing outcomes are highly predictable.
The ability of Cas9-mediated end-joining repair to induce frameshifts enables efficient gene knockout 5 . We reasoned that inDelphi's accurate prediction of indel lengths when considering nearly all editing products would enable accurate prediction of Cas9-induced frameshifts. We simulated this task in data from 82-91 endogenous target sites by tabulating the observed frequency of indels resulting in +0, +1 and +2 reading frames. In HEK293 cells, the observed frequency of indels in each frame predicted by inDelphi (median r = 0.81) compare favourably to those generated by 'Microhomology Predictor' , a previously published method 18 (median r = 0.37, Fig. 3d) , with similar results in HCT116 and K562 cells (Extended Data Fig. 4) . Thus, we expect inDelphi to facilitate Cas9-mediated gene knockout approaches by allowing a priori selection of gRNAs that induce high or low knockout frequencies. We note that microhomology deletions in human exons have a significant tendency to remain in-frame compared to non-coding human DNA (Extended Data Fig. 4 ).
Highly precise template-free Cas9 editing
Although end-joining repair is highly efficient in inducing mutations after Cas9 treatment, its propensity to induce a heterogeneous mixture of repair genotypes has limited applications for precision genome editing 19 . We used inDelphi to estimate the fraction of SpCas9 gRNAs targeting exons and introns in the human genome that support precise end-joining repair. Defining 'precision-x' gRNAs as those predicted to produce a single genotypic outcome in ≥x% of all major editing outcomes proximal to the cleavage site, inDelphi predicts that 28% and 47% of gRNAs are precision-30, whereas 5% and 11% of gRNAs are precision-50, when trained on mESC and U2OS cell data, respectively (Fig. 3f , Extended Data Table 1 ).
To test the accuracy of the predictions made using inDelphi of precise repair in endogenous settings, we selected 14 SpCas9 gRNAs predicted to induce precision-40 1-bp insertions. We delivered SpCas9 with gRNAs and performed endogenous HTS in human U2OS and HEK293T cells. We observed that 10 out of 14 predicted precision-40 1-bp insertion gRNAs induced a single 1-bp insertion genotype in ≥40% of edited products with an overall significantly higher precision (P < 4.2 × 10 −8 ) than baseline data in HEK293T (median 55% compared with 25% baseline in VO target sites in HEK293) and U2OS cells (median 57% compared with 14% baseline in lib-A, U2OS, Fig. 3e ). We similarly validated 10 gRNAs for high-precision deletions with endogenous HTS in both cell types (Extended Data Table 2 ). Collectively, these observations establish the ability of inDelphi to identify, from sequence features alone, gRNAs that induce significantly more precise editing than the general population of gRNAs. Article reSeArcH
Template-free correction of pathogenic alleles
We used inDelphi to identify new targets for therapeutic genome editing. Starting with 23,018 pathogenic short indels (ClinVar and HGMD databases 9, 10 ), we used inDelphi to identify pathogenic alleles that are suitable for template-free Cas9-mediated editing to effect precise gainof-function editing of the pathogenic genotype. We pursued two genetic disease allele categories that have not been previously identified as targets for Cas9-mediated repair: pathogenic frameshifts in which inDelphi predicts that 50-90% of Cas9-mediated deletion products will correct the reading frame (mean baseline frequency of 34% among disease-associated frameshift mutations) and pathogenic microduplication alleles in which a short sequence duplication leads to a frameshift mutation or disrupts protein function and which inDelphi predicts can be repaired to wild-type genotype in a large fraction of Cas9 editing products (Fig. 4a) .
We selected 1,592 pathogenic human loci with high predicted rates of frame correction or microduplication correction to the wild-type sequence for inclusion in a second library (lib-B). We observed that 183 human disease microduplication alleles included in lib-B were repaired to wild-type in ≥50% of all products (Fig. 4b) , and 508 pathogenic human frameshift alleles were corrected into proper reading frames in ≥50% of all products in mESCs (Fig. 4c) 
Lig4
-/-mESCs, the increased propensity towards MH deletions enabled a subset of pathogenic alleles to be repaired to wild type with markedly high precision. Compared to wild-type mESCs in which 183 pathogenic alleles corrected to wild type in ≥50% of all edited products and 11 pathogenic alleles corrected to wild type in ≥70% of all edited products, in Prkdc
-/-mESCs, 286 pathogenic alleles corrected to wild type in ≥50% of all edited products and 153 pathogenic alleles corrected to wild type in ≥70% of products ( 
-/-mESC alleles), MSH2 (88%) and LDLR (87%), supporting a model of competing end-joining repair mechanisms.
We further tested inDelphi's prediction of highly efficient correction in a functional assay with pathogenic LDLR microduplication alleles that cause dominantly inherited familial hypercholesterolemia 22 . We separately introduced five pathogenic LDLR microduplication alleles within a full-length LDLR coding sequence upstream of a P2A-GFP cassette into the genome of human and mouse cells, such that Cas9-mediated repair to the wild-type LDLR sequence should induce phenotypic gain of LDL uptake and restore the reading frame of GFP. We then delivered Cas9 and a gRNA that is specific to each pathogenic allele and does not target the wild-type repaired sequence. We observed robust restoration of LDL uptake as well as restoration of GFP fluorescence in mESCs, U2OS cells and HCT116 cells in up to 79% of cells following transfection with Cas9 and inDelphi gRNAs (Fig. 4e , f, Extended Data Fig. 7 ). HTS confirmed efficient correction of these five LDLR microduplication alleles to wild type in human and mouse cells, as well as pathogenic microduplication alleles in the GAA, GLB1 and PORCN genes introduced to cells using the same method (Extended Data Table 3 ). Importantly, in these experiments, we observed high-frequency LDLR phenotypic correction when cutting with either SpCas9 or Streptococcus aureus Cas9 (SaCas9) 23 (Extended Data Table 3 ). Finally, we used precise template-free Cas9-mediated MMEJ to correct pathogenic microduplication alleles endogenously in patientderived fibroblasts for Hermansky-Pudlak syndrome (HPS1 gene), which causes blood clotting deficiency and albinism in patients and is particularly common in Puerto Ricans
24
, and Menkes disease (ATP7A gene), which results in copper deficiency. Simultaneous delivery of Cas9 and gRNA specific to the pathogenic microduplication allele induced high-efficiency correction to the wild-type sequence in HPS1 (mean frequency, 88% of edited alleles, n = 5 independent biological experiments) and ATP7A (frequency, 94% of edited alleles, n = 2, Extended Data Table 2 ). These findings demonstrate the potential of template-free, precise Cas9-nuclease-mediated repair of microduplication alleles to achieve efficient repair to the wild-type sequence for therapeutic gain-of-function genome editing. , respectively), two-sided Welch's t-test. f, Smoothed predicted distribution of the highest frequency indel among major editing outcomes (+1 to −60 indels) for SpCas9 gRNAs targeting the human genome. 
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Discussion
We used the Cas9-mediated end-joining repair products of thousands of target DNA loci integrated into mammalian cells to train a machine learning model, inDelphi, that accurately predicts the spectrum of cut-site proximal genotypic products resulting from double-stranded break repair at a target DNA site of interest. The ability to predict Cas9-mediated products enables new precision genome editing research applications and facilitates existing applications, such as performing efficient bi-allelic gene knockout and predicting end-joining byproducts of HDR. We provide an online implementation of inDelphi to predict the spectrum of Cas9-mediated products along with predicted frameshift frequencies and precision at any target site (https://indelphi. giffordlab.mit.edu/).
The inDelphi model identifies target loci in which a substantial fraction of all repair products consist of a single genotype. Our findings suggest that 28-47% of SpCas9 gRNAs that target the human genome yield a single indel genotype in ≥30% of all major repair products (precision-30), and 5-11% yield a single indel genotype in ≥50% of all major repair products (precision-50). We show experimentally that precision template-free Cas9-mediated editing can mediate efficient gain-of-function repair at hundreds of pathogenic alleles including microduplications (Fig. 4b , e, f) in cell lines and in patient-derived primary cells (Extended Data Table 3 ). We note that each research or therapeutic Cas9-nuclease application may require a different level of precision depending on a variety of factors including risk/reward calculations of the gene and disease in question.
Moreover, we present evidence that suppressing NHEJ augments repair of pathogenic microduplication alleles, suggesting that temporary manipulation of DNA repair pathways could be combined with Cas9-mediated editing to favour specific editing genotypes with high precision. Genome editing currently lacks flexible strategies to correct indels in post-mitotic cells because of the limited efficiency of HDR in non-dividing cells 19 . As MMEJ is thought to occur throughout the cell cycle 25 , inDelphi may provide access to predictable and precise post-mitotic genome editing in a wider range of cell states. Incorporating the frequencies of long deletions and translocations 26, 27 into predictive models of Cas9 outcomes will be an important next step to calculate the overall precision of Cas9-nuclease editing. We anticipate that, given appropriate training data, inDelphi will also be able to accurately predict repair genotypes from other designer nucleases 5 . This work establishes that the prediction and judicious application of template-free Cas9 nuclease-mediated genome editing offers new capabilities for the study and potential treatment of genetic diseases.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-018-0686-x. Representative data for n = 2 independent biological replicates. Major editing outcomes include +1 to −60 indels. Predicted frequency of repair to restore wild-type frame among all major editing products (%) r = 0.64
Observed frequency of repair to restore wild-type frame among all edited products (%) 
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MEthodS
Data reporting.
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Library cloning. In brief, the cloning process involves ordering a library of oligonucleotides pairing a gRNA protospacer with its 55-bp target site, centred on an NGG PAM. To insert the gRNA hairpin between the gRNA protospacer and the target site, the library undergoes an intermediate Gibson Assembly circularization step, restriction enzyme linearization and Gibson Assembly into a plasmid backbone containing a U6 promoter to facilitate gRNA expression, a hygromycinresistance cassette and flanking Tol2 transposon sites to facilitate integration into the genome.
Specified pools of 2,000 oligonucleotides were synthesized by Twist Bioscience and amplified with NEBNext polymerase (New England Biolabs) using primers 'oligonucleotide library forward' and 'oligonucleotide library reverse' (see below), to extend the sequences with overhangs complementary to the donor template used for circular assembly. To avoid overamplification in the library cloning process, we first performed qPCR by addition of SybrGreen Dye (Thermo Fisher) to determine the number of cycles required to complete the exponential phase of amplification. We ran the PCR reaction for half of the determined number of cycles at this stage. Extension time for all PCR reactions was extended to 1 min per cycle to prevent skewing towards GC-rich sequences. The 246-bp fragment was purified using a PCR purification kit (Qiagen).
Separately, the donor template for circular assembly was amplified with NEBNext polymerase for 20 cycles from an SpCas9 sgRNA expression plasmid (Addgene 71485) 21 using primers 'circular donor forward' and 'circular donor reverse' (see below) to amplify the sgRNA hairpin and terminator, and extended further with a linker region meant to separate the gRNA expression cassette from the target site in the final library. The 146-bp amplicon was gel-purified (Qiagen) from a 2.5% agarose gel.
The amplified synthetic library and donor templates were ligated by Gibson Assembly (New England Biolabs) in a 1:3 molar ratio for 1 h at 50 °C, and unligated fragments were digested with Plasmid Safe ATP-Dependent DNase (Lucigen) for 1 h at 37 °C. Assembled circularized sequences were purified using a PCR purification kit (Qiagen), linearized by digestion with SspI (New England Biolabs) for ≥3 h at 37 °C, and the 237-bp product was gel-purified (Qiagen) from a 2.5% agarose gel.
The linearized fragment was further amplified with NEBNext polymerase using primers 'plasmid insert forward' and 'plasmid insert reverse' (see below) for the addition of overhangs complementary to the 5′ and 3′ regions of a Tol2 transposon containing gRNA expression plasmid (Addgene 71485) 21 previously digested with BbsI and XbaI (New England Biolabs), to facilitate gRNA expression and integration of the library into the genome of mammalian cells. To avoid overamplification, we performed qPCR by addition of SybrGreen Dye (Thermo Fisher) to determine the number of cycles required to complete the exponential phase of amplification, and then ran the PCR reaction for the determined number of cycles. The 375-bp amplicon was gel-purified (Qiagen) from a 2.5% agarose gel.
The 375-bp amplicon and double-digested Tol2 transposon containing gRNA expression plasmid were ligated by Gibson Assembly (New England Biolabs) in a 3:1 ratio for 1 h at 50 °C. Assembled plasmids were purified by isopropanol precipitation with GlycoBlue Coprecipitant (Thermo Fisher) and reconstituted in milliQ water and transformed into NEB10beta (New England Biolabs) electrocompetent cells. Following recovery, a small dilution series was plated to assess transformation efficiency and the remainder was grown in liquid culture in DRM medium overnight at 37 °C. A detailed step-by-step library cloning protocol is provided in the Supplementary Methods.
The plasmid library was isolated by Midiprep plasmid purification (Qiagen). Library integrity was verified by restriction digest with SapI (New England Biolabs) for 1 h at 37 °C, and sequence diversity was validated by HTS as described below. Library cloning primers. Oligonucleotide library forward: 5′-TTTT TGTTTTCTGTGTTCCGTTGTCCGTGCTGTAACGAAAGGATGGGTGCGAC GCGTCAT-3′; oligonucleotide library reverse: 5′-GTTGATAACGGACTAGCC TTATTTAAACTTGCTATGCTGTTTCCAGCATAGCTCTTAAAC-3′; circular donor forward: 5′-GTTTAAGAGCTATGCTGGAAACAGC-3′; circular donor reverse: 5′-ATGACGCGTCGCACCCATCCTTTCGTTACAGC ACGGACAACGGAACACAGAAAACAAAAAAGCACCGACTC-3′; plasmid insert forward: 5′-GTAACTTGAAAGTATTTCGATTTCTTGGCTTTATATATC TTGTGGAAAGGACGAAACACC-3′; plasmid insert reverse: 5′-TTGTGGTTT GTCCAAACTCATCAATGTATCTTATCATGTCTGCTCGAAGCGGCCGTACC TCTAGAT TCAGACGTGTGCTCTTCCGATCT-3′. Cloning. A base plasmid was constructed starting from a Tol2-transposoncontaining plasmid (Addgene 71485) 21 . The sequence between Tol2 sites was replaced with a CAGGS promoter, multi-cloning site, P2A peptide sequence followed by eGFP sequence, and puromycin-resistance cassette to produce p2T-CAG-MCS-P2A-GFP-PuroR. The full sequence of this plasmid is appended in the 'Sequences' section of the Supplementary Methods, and this plasmid has been submitted to Addgene as catalogue number 107186. Plasmids with this backbone and containing wild-type and microduplication mutation versions of LDLR and three other genes, GAA, GLB1, and PORCN, were constructed. Information on cloning these genes is provided below, and the gene sequences are appended in the Supplementary Methods.
LDLR: To generate p2T-CAGGS-LDLRwt-P2A-GFP-PuroR, LDLR (NCBI gene ID 3949, transcript variant 1 CDS) was PCR-amplified from a base plasmid ordered from the Harvard PlasmID resource core and cloned between the BamHI and NheI sites of the base plasmid. The following mutants were generated through InFusion (Clontech) cloning. Sequences are provided below, and our internal allele nomenclature is in parentheses: LDLR: c.526_533dupGGCTCGGA (LDLRdup252); LDLR: c.668_681dupAGGACAAATCTGAC (LDLRdup254/255); LDLR: c.669_680dupGGACAAATCTGA (LDLRdup258); LDLR: c.672_683dup-CAAATCTGACGA (LDLRdup261); LDLR: c.1662_1669dupGCTGGTGA (LDLRdup264).
PORCN: NCBI gene ID 64840, transcript variant C CDS was PCR-amplified from HCT116 cDNA and cloned between the BamHI and NheI sites of the base plasmid. PORCN: c.1059_1071dupCCTGGCTTTTATC (PORCNdup20) was generated through InFusion cloning.
GLB1: NCBI gene ID 2720, transcript variant 1 CDS was PCR-amplified from HCT116 cDNA and cloned between the BamHI and NheI sites of the base plasmid. GLB1: c.1456_1466dupGGTGCATATAT (GLB1dup84) was generated through InFusion cloning.
GAA: NCBI gene ID 2548, transcript variant 1 CDS was PCR-amplified from a base plasmid ordered from the Harvard PlasmID resource core and cloned between the BamHI and NheI sites of the base plasmid. GAA: c.2704_2716dupCAGAAG-GTGACTG (GAAdup327/328) was generated through InFusion cloning. 21 . The sequence between Tol2 sites was replaced with a CAGGS promoter, Cas9 sequence, and blasticidin-resistance cassette to produce p2T-CAG-SpCas9-BlastR and p2T-CAG-KKHSaCas9-BlastR. These plasmids have been submitted to Addgene as catalogue numbers 107189 and 107190.
SpCas9 gRNAs were cloned as a pool into a Tol2-transposon-containing gRNA expression plasmid (Addgene 71485) 21 using BbsI plasmid digest and Gibson Assembly (New England Biolabs). SaCas9 gRNAs were cloned into a similar Tol2-transposon-containing SaCas9 gRNA expression plasmid (p2T-U6-sgSaCas2 x BbsI-HygR), which has been submitted to Addgene using BbsI plasmid digest and Gibson Assembly. Protospacer sequences used are listed below, using our internal nomenclature which matches the duplication alleles.
LDLR gRNAs: sgsaLDLRdup252, 5′-GCTGCGAAGATGGCTCGGAGGC-3′; sgsaLDLRdup254, 5′-GTGCAAGGACAAATCTGACAGG-3′; sgsaLDLRdup255, 5′-GTTCCTCGTCAGATTTGTCCTG-3′; sgsaLDLRdup258, 5′-GACTG CAAGGACAAATCTGAGG-3′; sgsaLDLRdup261, 5′-GTTTTCCTCGTC AGATTTGTCG-3′; sgspLDLRdup264, 5′-GACATCTACTCGCTGGTGAGC-3′. PORCN gRNAs: sgspPORCNdup20, 5′-GCTGTCCCTGGCTTTTATCCC-3′. GLB1 gRNAs: sgspGLB1dup84, 5′-GTGTGAACTATGGTGCATATA-3′. GAA gRNAs: sgsaGAAdup327, 5′-GCAGCTGCAGAAGGTGACTGCA-3′; sgspGAAdup328, 5′-GCTGCAGAAGGTGACTGCAGA-3′. Cell culture. mESC lines used have been described previously and were cultured as described previously 29 . HEK293T, HCT116, and U2OS cells were purchased from ATCC and cultured as recommended by ATCC. The following cell lines were obtained and cultured as recommended from the NIGMS Human Genetic Cell Repository at the Coriell Institute for Medical Research: GM14609 HermanskyPudlak Syndrome 1 (HPS1) fibroblasts and GM13672 Menkes Syndrome fibroblasts. Cell lines were authenticated by the suppliers and tested negative for mycoplasma.
For stable Tol2 transposon plasmid integration, cells were transfected using Lipofectamine 3000 (Thermo Fisher) following standard protocols with equimolar amounts of Tol2 transposase plasmid 15 (a gift from K. Kawakami) and transposon-containing plasmid. For library applications, 15-cm plates with >10 7 initial cells were used, and for single gRNA targeting, 6-well plates with >10 6 initial cells were used. To generate lines with stable Tol2-mediated genomic integration, selection with the appropriate selection agent at an empirically defined concentration (blasticidin, hygromycin, or puromycin) was performed starting 24 h after transection and continuing for >1 week. In cases where sequential plasmid integration was performed such as integrating gRNA/target library and then Cas9 or microduplication plasmid and then Cas9 plus gRNA, the same Lipofectamine 3000 transfection protocol with Tol2 transposase plasmid was performed each time, and >1 week of appropriate drug selection was performed after each transfection.
For SpCas9 targeting experiments, cells were transduced with a single lentivirus containing an SpCas9 and sgRNA expression cassette to target SpCas9 cleavage to either the HPS1: c.1472_1487dup16 or ATP7A: c.6913_6917dupCTTAT microduplication locus for use in HPS1 and Menkes Syndrome fibroblasts, respectively. The lentiviral plasmids were obtained from (LV01, Sigma-Aldrich) and lentivirus was produced by the Boston Children's Hospital Viral Core. Fibroblasts were plated in 12-well plates at 12,500 cells cm -2 one day before transduction. Cells were treated with 10-20 µl of virus in the presence of 8 µg ml -1 Polybrene (Sigma-Aldrich) on two consecutive days and collected on day 10 after transduction. Apoptosis analysis. Wild-type and Prkdc −/− Lig4 −/− mESCs with stably integrated Lib-A were transfected with p2T-CAG-SpCas9-P2A-GFP-PuroR using Lipofectamine 3000 following standard protocols in 6-well plates with 10 6 cells. After 24 h, cells were stained with Annexin V Alexa Fluor 568 conjugate (Thermo Fisher) according to the manufacturer's protocols. Fluorescence was detected on a Cytoflex LX (Beckman Coulter) and analysed using FlowJo (FlowJo LLC). Deep sequencing. Genomic DNA was collected from cells after >1 week of selection. For library samples, 16 µg gDNA was used for each sample; for individual locus samples, 2 µg gDNA was used; for plasmid library verification, 0.5 µg purified plasmid DNA was used.
For individual locus samples, the locus surrounding CRISPR-Cas9 mutation was PCR-amplified in two steps using primers >50-bp from the Cas9 target site. PCR1 was performed using the primers specified below. PCR2 was performed to add full-length Illumina sequencing adapters using the NEBNext Index Primer Sets 1 and 2 (New England Biolabs) or internally ordered primers with equivalent sequences. All PCRs were performed using NEBNext polymerase. Extension time for all PCR reactions was extended to 1 min per cycle to prevent skewing towards GC-rich sequences. The pooled samples were sequenced using NextSeq (Illumina) at the Harvard Medical School Biopolymers Facility, the MIT BioMicro Center, or the Broad Institute Sequencing Facility. The library prep primers were as follows. For LDLRDup252, 254, 255, 258, 261:120417_ LDLRDup254_r1seq_A, 5′-CTTTCCCTACACGACGCTCTTCCGATCT NNN ACTCCAGCTGGCGCTGTGAT-3′; 120417_LDLR254_r2seq_A, 5′-GGA GTTCAGACGTGTGCTCTTCCGATCTCAACTTCATCGCTCATGTCCTTG-3′. For LDLRDup264: 120817_LDLR264_r1seq_B, 5′-CTTTCCCTACACGA CGCTCTTCCGATCTNNN AACTCCCGCCAAGATCAAGAAAG-3′; 120817_ LDLR264_r2seq_B, 5′-GGAGTTCAGACGTGTGCTCTTCCGATCTCAG CCTCTTTTCATCCTCCAAGA-3′. For PORCDup20: 120517_PORCN20_ r1seq, 5′-CTTTCCCTACACGACGCTCTTCCGATCTNNNC CTCCTACATGG CTTCAGTTTCC-3′; 120517_PORCN20_r2seq, 5′-GGAGTTCAGACGTG TGCTCTTCCGATCTCCAGAGCTCCAAAGAGCAAGTTT-3′. For GLB1Dup84: 120517_GLB184_r1seq, 5′-CTTTCCCTACACGACGCTCTTCCGATCTNNN AGCCACTCTGGACCTTCTGGTA-3′; 120517_GLB184_r2seq, 5′-GGAG TTCAGACGTGTGCTCTTCCGATCTCCAGTCCGTGAGGATATTGGAAC-3′. For GAADup327/328: 120517_GAA327_r1seq, 5 ′-CT TT CC CT AC AC GA CG C T CT TC CG AT CT NN NG AT CG TG AATGAGCTGGTACGTG-3′; 120517_ GAA327_r2seq, 5′-GGAGTTCAGACGTGTGCTCTTCCGATCTAACAGCGA GACACAGATGTCCAG-3′. General HTS data analysis and computational modelling. A detailed and thorough description of methods used for data analysis and computational modelling is available in the Supplementary Methods. Statistical analysis and reproducibility. Python 2.7 and 3.6 were used to analyse data and perform statistical tests using the SciPy library. Data are represented as mean ± standard error of the mean with 95% confidence intervals. In box plots, box segments show median, 25th and 75th percentiles, whiskers above and below show 1.5 times the interquartile range. Higher and lower points (outliers) are plotted individually or not plotted. Comparison of means of two independent groups was performed using two-sided two-sample t-tests, for which the validity of the normal assumption was analysed using the Shapiro-Wilk tests for small data (n < 50 samples) and/or using the Kolmogorov-Smirnov test on larger data (n > 50) directly, and/or using the Kolmogorov-Smirnov test on bootstrapped means (n = 1,000 bootstrapped samples). In all significance tests performed in the study, the data satisfied our normality criteria for t-tests. For comparison of two independent groups, two-sided two-sample t-tests were used for normally distributed data with equal or similar variance (Student's t-test) or unequal and dissimilar variance (Welch's t-test). A critical value for significance of P < 0.05 was used throughout the study.
Here, we report detailed statistical parameters (P value, name of statistical test, test statistic value, degrees of freedom (d.f.), effect size) for all significance tests performed in the study. , test statistic = 9.49, d.f. = 3,130.82, Hedges' g = 0.29). Extended Data Fig. 7f , box plot comparing observed 1-bp insertion frequency in lib-A and 12 pathogenic alleles selected by inDelphi in mESCs (combined data from n = 2 independent biological replicates). The box denotes the 25th, 50th and 75th percentiles, whiskers show 1.5 times the interquartile range, and outliers are depicted d.f. = 11.18, Hedges' g effect size = 1.47. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Code availability. All data processing, analysis and modelling code is available at www.github.com/gifford-lab/inDelphi-dataprocessinganalysis. The inDelphi model is available online at https://indelphi.giffordlab.mit.edu/. 374  375  375  375  372  375  375  375  375  375  375  375  372  375  375  375  375  372 biological replicates) and U2OS cells (combined data from n = 2 independent biological replicates). For 'all' , the original non-subsampled data are presented. Each box depicts data for 2,000 target sites. Outliers are not depicted. e, Pearson's r of genotype frequencies comparing lib-A in mESCs and U2OS cells with endogenous data in HEK293 (n = 87 target sites), HCT116 (n = 88), and K562 (n = 86) cells. Outliers are depicted as diamonds. 1-bp insertion frequency adjustment was performed at each target site by proportionally scaling them to be equal between two cell types. f, Pearson's r of genotype frequencies at lib-A target sites, comparing two independent biological replicate experiments in mESCs (n = 1,861 target sites, median r = 0.89) and U2OS cells (n = 1,921, median r = 0.77). Outliers are depicted as diamonds. Box plots denote the 25th, 50th and 75th percentiles and whiskers show 1.5 times the interquartile range. Other, 9%
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Ins. 37%
Deletions 63%
Non-MH del. 20% ATGC  CTGT  CTAC  CAGA  TAGT  ATCT  ACGC  CTAT  ATGT  CACT  ACGT  TAGA  GCGA  CTAG  ACTG  GTAT  GTGC  TACA  GCTA  ATCG  GCGT  TACG  GCAC  CATG  GATG  CTCA  GTCG  GCTC  TCGT  GTCT  GTAC  GCTG  TATG  ACTC  GTGA  CTCG  ATCA  GAGC  TGCT  ACAT  AGTC  GACT  GCAT  AGCG  TCAC  TGTC  TCTA  GAGT  CGTC  TATC  GTAG  CACG  TGCA  TGTA  GTGT  CATC  AGTA  TCTG  GATA  TCGC  GATC  TGAG  CGTG  ATAC  GACA  AGTG  ATAG  GCGC  TGCG  AGAC  TAGC  ATAT  CGAT  TGAC  CGCT  CAGT  CGCA  AGAT  GAGA  CATA  CTCT  CACA  ACAC  AGCT  ACAG  CGAC  TATA  TCAG  CGCG  TGTG  AGAG  TCTC  CCCC  TTTT  GGGG CTAC  GTGA  CATG  ACTG  CTGA  GTCG  CACT  CTCG  ATGC  GTAT  GTAG  AGTC  GAGT  ATCG  CTCA  TCGA  CTAT  GATG  GTGT  GTCT  GCTG  CGTC  GTGC  ACGC  TACG  TATG  GCGT  GCGA  GCAT  GCTC  ATGT  GACA  TACA  ATAC  CTAG  ACTA  CGTG  ATCT  CAGA  GATC  AGCG  GTAC  ACAT  GAGC  AGTA  TCAC  CATA  GCAC  AGTG  GCTA  GATA  ACAC  TAGA  TGAC  TAGC  CGTA  TGAG  CATC  CGAG  ATAT  ACAG  GAGA  TCTC  CTGT  CACA  CGAC  TATA  TGTC  TGCA  TCGT  GACT  CGAT  ACTC  CACG  CCCC  CTCT  AAAA  TGCG  TGTG  GCGC  ATCA  TCTA  TCGC  CAGT  CGCT  ATAG  TATC  CGCA  TGCT  CGCG  AGAC  TGTA  TCTG  TAGT  AGAG  AGAT  TTTT  GGGG Methods) called by simulating data subsampling in data at 2,000 lib-B target sites in mESCs (combined data from n = 2 independent technical replicates) and U2OS cells (combined data from n = 2 independent biological replicates). In 'all' , the full non-subsampled data are presented (see Supplementary Table 2 Table of Pearson's r of the change in disease correction frequency compared to wild-type at n = 791 target sites for each pair of conditions. f, g, Annexin V-568 staining flow cytometry contour plots (f) and mean ± standard deviation values (g) in wild-type and Prkdc −/− Lig4 −/− lib-A mESCs following transfection with SpCas9-P2A-GFP (representative data for n = 2 experiments). Box plots denote the 25th, 50th and 75th percentiles, whiskers show 1.5 times the interquartile range, and outliers are depicted as diamonds. For detailed statistics on significance tests, see Methods. 
Microhomology deletions 39%
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code
Data collection
No software was used to collect the data.
Data analysis
Custom Python code used for data analysis is available at "https://github.com/maxwshen/crispr-indelphi-dataprocessinganalysis". FlowJo (FlowJo LLC) version 10.5.0 was used for fluorescence analysis.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: All studies must disclose on these points even when the disclosure is negative.
Sample size
Sequencing depth was chosen to obtain a minimum average of 5,000 reads per designed library oligo based on empirical measurements (using preliminary sequencing) of the distribution of coverage over library oligos.
Data exclusions When calculating statistics of interest on processed data, sequence contexts with less than 500 reads for the relevant subset of data were excluded. For training and testing the predictive model, sequence contexts with between-replicate replicability of MH deletions below r = 0.85 were excluded. Exclusion criteria were not pre-established.
Replication
Experimental replicates were performed for Lib-A mESC, primary fibroblast HPS1, mESC PORCN, mESC GLB1, and mESC LDLR264 which also serves as a cross-celltype replicate for HCT116 LDLR264. Technical replicates were performed for Lib-B mESC, Lib-B U2OS, and Lib-B HEK293T. All experimental replicates were successful. In addition, no-Cas9 control experiments were performed for Lib-A mESC, Lib-B mESC, primary fibroblast HPS1, Lib-B U2OS, and Lib-B HEK293T. Treatment data were adjusted using control data.
Randomization Randomized allocation of cells to experimental groups was not relevant to our study. Between treatment and control groups, the impact of cell-to-cell variability is reduced to negligible amounts by ensuring a minimum cell population diversity of 2,000 cells per designed library oligo and an average of 5,000 reads per designed library oligo.
Blinding
Blinding was not relevant to our study. Treatment data was statistically adjusted using control data.
Reporting for specific materials, systems and methods 
Mycoplasma contamination
Cells were tested every month for mycoplasma contamination and were always negative.
Commonly misidentified lines (See ICLAC register)
No commonly-misidentified lines were used in this study.
